Literature DB >> 8647160

Identification of a novel subpopulation of germinal center B cells characterized by expression of IgD and CD70.

S M Lens1, R M Keehnen, M H van Oers, R A van Lier, S T Pals, G Koopman.   

Abstract

CD27, which belongs to the tumor necrosis factor receptor family, is expressed on germinal center (GC) but not on naive B cells, suggesting an important function of this molecule in the regulation of the GC reaction. We described here the expression of CD70, which is the ligand for CD27. We observed that in most tonsils, CD70 is only expressed on part of the IgD-, CD38- B cell population, which have been described as memory B cells. However, in 10% of the tonsils tested, CD70+ IgD+ GC were found. The CD70+ GC B cells were small cells that also expressed CD44 and CD39, but were CD10- and CD38-, suggesting that they represent very recent immigrants that are in the process of forming a GC. The concordant expression of CD27 and its ligand CD70 on this primordial subset of GC B cells suggests an important role for CD27/CD70 interaction at this stage of GC formation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8647160     DOI: 10.1002/eji.1830260508

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  3 in total

1.  Antigen-presenting cell-derived signals determine expression levels of CD70 on primed T cells.

Authors:  S M Lens; P A Baars; B Hooibrink; M H van Oers; R A van Lier
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

2.  The relationship between CD27 negative and positive B cell populations in human peripheral blood.

Authors:  Yu-Chang Bryan Wu; David Kipling; Deborah K Dunn-Walters
Journal:  Front Immunol       Date:  2011-12-26       Impact factor: 7.561

3.  Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells.

Authors:  U Klein; K Rajewsky; R Küppers
Journal:  J Exp Med       Date:  1998-11-02       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.